Avanos Medical (AVNS) Gross Profit (2013 - 2026)

Avanos Medical's Gross Profit history runs 14 years deep, the most recent figure standing at $94.2 million for Q1 2026.

• In Q1 2026, Gross Profit rose 4.9% year-over-year to $94.2 million; the TTM figure through Mar 2026 stood at $358.3 million (down 4.78% YoY), while the FY2025 annual figure was $353.9 million, down 7.19% from the prior year.
• Gross Profit came in at $94.2 million for Q1 2026 at Avanos Medical, up from $86.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $106.6 million in Q1 2022 to a low of $86.0 million in Q3 2025.
• A 5-year average of $95.3 million and a median of $95.0 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 218.58% in 2022 and retreated 14.26% in 2023, its largest moves.
• Avanos Medical's Gross Profit stood at $102.9 million in 2022, then decreased by 7.68% to $95.0 million in 2023, then advanced by 3.16% to $98.0 million in 2024, then dropped by 12.24% to $86.0 million in 2025, then advanced by 9.53% to $94.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $94.2 million, $86.0 million, and $86.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison